Dimethylformamide → tert-butyl (2R)-2-[(2R)-4-(4-chlorophenyl)-3-oxomorpholin-2-yl]-2-hydroxyacetate
反応式
[Cl:1][C:2]1[CH:24]=[CH:23][C:5]([N:6]([C:10](=[O:22])[C@H:11]([OH:21])[C@@H:12]([OH:20])[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[CH2:7][CH2:8]Cl)=[CH:4][CH:3]=1.CN(C=O)C>CC(O)(C)C.CS(C)=O>[Cl:1][C:2]1[CH:24]=[CH:23][C:5]([N:6]2[CH2:7][CH2:8][O:21][C@H:11]([C@@H:12]([OH:20])[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[C:10]2=[O:22])=[CH:4][CH:3]=1参加物
4
実験手順
According to the Step 7-5 in synthetic method for EXAMPLE 7, compound 60-4 (1.78 g) and DMF were used instead of 7-4 and t-BuOH-DMSO to obtain compound 60-5 (400 mg) as a pale yellow amorphous solid.
出典と根拠
- ORDレコード
- ord-1f622ecd6ab84a8e9fa7a4930cc1304f
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08987242B2
反応ノート
読み込み中…